• Home
  • NEW DAY MEDICINE
  • 1 (29) 2020 г.
  • 73 -1 (29/2) 2020 — Maxmudov F.A., Latipov I.I., — VITILIGO EXTENT TENSITY INDEX (VETI) SCORE: A NEW DEFINITION, ASSESSMENT AND TREATMENT EVALUATION CRITERIA IN VITILIGO

73 -1 (29/2) 2020 — Maxmudov F.A., Latipov I.I., — VITILIGO EXTENT TENSITY INDEX (VETI) SCORE: A NEW DEFINITION, ASSESSMENT AND TREATMENT EVALUATION CRITERIA IN VITILIGO

VITILIGO EXTENT TENSITY INDEX (VETI) SCORE: A NEW DEFINITION, ASSESSMENT AND TREATMENT EVALUATION CRITERIA IN VITILIGO

Maxmudov F.A., Bukhara State Medical institute.

Latipov I.I., Bukhara State Medical institute.

Ozodov J.H., Bukhara State Medical institute.

Yusupov D.A., Bukhara State Medical institute.

Resume,

The purpose of this manuscript was to combine VETF and VASI system and develop a practical and standardized scoring system similar to PASI score with the aim to assess the treatment response and evaluate changes in affected area. Additionally it has a potential to be a source of any computed application for researchers who work on vitiligo patients.

Key words: Vitiligo, VETF – The Vitiligo European Task Force, PASI, VASI – The Vitiligo Area Scoring Index, VIDA – Vitiligo Disease Activity Score, VETI – Vitiligo Extent tensity Index score, PRI – Potential Repigmentation Index, repigmentation, depigmentation.

First page

268

Last page

271

For citation: Maxmudov F.A., Latipov I.I., Ozodov J.H., Yusupov D.A., Vitiligo extent tensity index (veti) score: a new definition, assessment and treatment evaluation criteria in vitiligo//New Day in Medicine 1(29)2020 268-271 https://cutt.ly/2vNWQOl

List of References

  1. Bhor U., Pande S. Scoring systems in dermatology. //Indian J Dermatol Venereol Leprol. 2016; 72: 315-21. [PubMed] [Google Scholar]
  2. Pf?tze M., Niedermeier A., Hertl M., Eming R. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. // Eur J Dermatol. 2007; 17: 4-11. [PubMed] [Google Scholar]
  3. Hamzavi I., Jain H., McLean D., Shapiro J., Zeng H., Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo, using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch // Dermatol. 2014; 140: 677-683. [PubMed] [Google Scholar]
  4. Ta?eb A., Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. // Pigment Cell Res. 2007; 20: 27-35. [PubMed] [Google Scholar]
  5. PASI Calculator. http://pasi.corti.li/ Psoriasis Area Severity Index (PASI) Calculator (1.7.1). Accessed December 30, 2013.
  6. Wong P.C., Leung Y.Y., Li E.K., Tam L.S. Measuring disease activity in psoriatic arthritis. // Int J Rheumatol. 2012; 2012: 839425. [PMC free article] [PubMed] [Google Scholar]
  7. Fredriksson T., Pettersson U. Severe psoriasis-oral therapy with a new retinoid. // Dermatologica.1978; 157: 238-44. [PubMed] [Google Scholar]
  8. Benzekri L., Ezzedine K., Gauthier Y. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy. // Br J Dermatol. 2013; 168: 1143-6. [PubMed] [Google Scholar]
  9. Aydin F., Senturk N., Sahin B., et al. A practical method for the estimation of vitiligo surface area: a comparison between the point counting and digital planimetry techniques. // Eur J Dermatol. 2007; 17: 30-2. [PubMed] [Google Scholar]
  10. Njoo M.D., Das P.K., Bos J.D., Westerhof W. Association of the K?bner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. // Arch Dermatol. 1999; 135: 407-13. [PubMed] [Google Scholar]
  11. Wachtel T.L., Berry C.C., Wachtel E.E., Frank H.A. The inter­rater reliability of estimating the size of burns from various burn area chart drawings. // Burns. 2000; 26: 156-70. [PubMed] [Google Scholar]
  12. Feily A., Baktash D., Mohebbipour A., Feily A. Potential advantages of simvastatin as a novel anti-vitiligo arsenal. // Eur Rev Med Pharmacol Sci. 2013; 17: 1982-3. [PubMed] [Google Scholar]
  13. Feily A., Namazi M.R. Silymarin as a potential novel addition to the limited anti-vitiligo weaponry: an untested hypothesis. // Int J Clin Pharmacol Ther. 2011; 49: 467-8. [PubMed] [Google Scholar]
  14. Kawakami T., Hashimoto T. Disease severity indexes and treatment evaluation criteria in vitiligo. // Dermatol Res Pract. 2011; 2011: 750342. [PMC free article] [PubMed] [Google Scholar]

file

download